James Hamilton

Medicine & Life Sciences

1. Adenocarcinoma 55%
2. Antiviral Agents 28%
3. Barrett Esophagus 77%
4. Bilirubin 15%
5. Biomarkers 34%
6. bromopyruvate 15%
7. Budd-Chiari Syndrome 15%
8. Carcinogenesis 15%
9. Colonic Neoplasms 16%
10. Copper 29%
11. Copper Transport Proteins 22%
12. Coronavirus 38%
13. DNA 17%
14. End Stage Liver Disease 21%
15. Epigenomics 43%
16. Esophageal Neoplasms 37%
17. Esophageal Squamous Cell Carcinoma 30%
18. Esophagus 18%
19. Fatty Liver 22%
20. Fibrosis 17%
21. Genes 35%
22. Hepacivirus 18%
23. Hepatic Stellate Cells 21%
24. Hepatitis B 17%
25. Hepatocellular Carcinoma 68%
26. Hepatocytes 24%
27. Hepatolenticular Degeneration 63%
28. Immunoglobulins 15%
29. Liver 56%
30. Liver Cirrhosis 18%
31. Liver Diseases 46%
32. Liver Neoplasms 27%
33. Liver Transplantation 100%
34. Liver X Receptors 24%
35. Messenger RNA 15%
36. Methylation 83%
37. MicroRNAs 22%
38. Mortality 19%
39. Multicenter Studies 15%
40. Neoplasms 35%
41. Non-alcoholic Fatty Liver Disease 20%
42. Nucleosides 18%
43. Ouabain 19%
44. polo-like kinase 1 15%
45. Somatostatin 18%
46. Stomach Neoplasms 23%
47. Tachykinins 23%
48. Therapeutics 17%
49. Tissue Donors 22%
50. Transplant Recipients 24%